Because extrahepatic and hepatic cancers are also leading causes of death in patients with NAFLD and NASH, the ability of exercise to improve FGF21 resistance offers promise as a mechanism of interest to explore as we continue to tease out the protective benefit of regular physical activity on oncologic risk [43,44]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatohepatitis.